Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Oncology|February 5, 2010
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group StudyAmy D Tiersten, James Moon, Harriet O Smith, et al.Infection and Immunity|August 24, 2006
Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosisJames I Ito, Joseph M Lyons, Teresa B Hong, et al.Gynecologic Oncology|January 14, 2009
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009Amy D Tiersten, P Y Liu, Harriet O Smith, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 11, 2014
Merkel cell carcinoma of lymph node with unknown primary has a significantly lower association with Merkel cell polyomavirus than its cutaneous counterpartZenggang Pan, Yuan-Yuan Chen, Xiaojun Wu, et al.Cancer Research|April 19, 2003
Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infectionIgor Kuzmin, Limin Liu, Reinhard Dammann, et al.Journal of Virology|May 22, 2009
Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in cultureMichael J Lace, Christina Isacson, James R Anson, et al.Genes, Chromosomes & Cancer|May 29, 2008
Inactivation of the cystatin E/M tumor suppressor gene in cervical cancerMysore S Veena, Grant Lee, Daniel Keppler, et al.Cancer Research|January 25, 2005
Tumor susceptibility of Rassf1a knockout miceStella Tommasi, Reinhard Dammann, Zhongqiu Zhang, et al.Gynecologic Oncology|October 24, 2007
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)David S Alberts, P Y Liu, Sharon P Wilczynski, et al.Molecular Cancer Research : MCR|April 9, 2009
Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5)Philip M Carpenter, Anh V Dao, Zahida S Arain, et al.Pageof 3